Efficient expression of nuclear transgenes in the green alga Chlamydomonas: synthesis of an HIV antigen and development of a new selectable marker
- First Online:
- Cite this article as:
- Barahimipour, R., Neupert, J. & Bock, R. Plant Mol Biol (2016) 90: 403. doi:10.1007/s11103-015-0425-8
- 2.2k Downloads
The unicellular green alga Chlamydomonas reinhardtii has become an invaluable model system in plant biology. There is also considerable interest in developing this microalga into an efficient production platform for biofuels, pharmaceuticals, green chemicals and industrial enzymes. However, the production of foreign proteins in the nucleocytosolic compartment of Chlamydomonas is greatly hampered by the inefficiency of transgene expression from the nuclear genome. We have recently addressed this limitation by isolating mutant algal strains that permit high-level transgene expression and by determining the contributions of GC content and codon usage to gene expression efficiency. Here we have applied these new tools and explored the potential of Chlamydomonas to produce a recombinant biopharmaceutical, the HIV antigen P24. We show that a codon-optimized P24 gene variant introduced into our algal expression strains give rise to recombinant protein accumulation levels of up to 0.25 % of the total cellular protein. Moreover, in combination with an expression strain, a resynthesized nptII gene becomes a highly efficient selectable marker gene that facilitates the selection of transgenic algal clones at high frequency. By establishing simple principles of successful transgene expression, our data open up new possibilities for biotechnological research in Chlamydomonas.
KeywordsChlamydomonas reinhardtii Molecular farming HIV Antigen Selectable marker gene Transformation
The unicellular green alga Chlamydomonasreinhardtii is widely used as a model organism for research on fundamental questions in cell and molecular biology, including chloroplast biology, photosynthesis, light perception and signaling as well as flagellar function and tactic movements (Harris 2001; Merchant et al. 2007). In its vegetative phase, Chlamydomonas is a haploid organism and can be grown photoautotrophically, mixotrophically or heterotrophically (using acetate as the sole source of organic carbon; Harris 1989). Triggered by environmental cues, two vegetative cells of opposite mating types (mt+ and mt−) can differentiate into gametes and engage in sexual reproduction. All three genomes of the alga (in the nucleus, the plastid and the mitochondria) are completely sequenced (Merchant et al. 2007) and can be stably transformed (Kindle et al. 1991; Remacle et al. 2006; Neupert et al. 2012).
The ease with which Chlamydomonas can be cultured in large volumes and the ease with which it can be genetically engineered have also made the alga a preferred model organism in biotechnological research, especially for metabolic engineering, biofuel production and the synthesis of proteinaceous biopharmaceuticals and industrial enzymes, an area commonly referred to as molecular farming (Scaife et al. 2015; Scranton et al. 2015). However, harnessing the full potential of Chlamydomonas in biotechnology turned out to be challenging because of severe problems with (i) the expression of nuclear transgenes to reasonable levels (Fuhrmann et al. 1999; Schroda et al. 2000), and (ii) epigenetic transgene inactivation mechanisms that cause loss of expression with time (Yamasaki et al. 2008). Although introduction of transgenes into the nuclear genome of the alga is straightforward, the isolation of transgenic strains that express the foreign gene of interest to detectable levels, in many cases, has turned out to present an unsurmountable challenge (Mussgnug 2015). Identification of promoters suitable to drive strong transcription of heterologous genes (Fischer and Rochaix 2001), construction of hybrid promoters (Schroda et al. 2000) and resynthesis of the coding region of the transgene to adjust its codon usage to that of the Chlamydomonas nuclear genome (Fuhrmann et al. 1999, 2004; Shao and Bock 2008), has led to some improvements, but did not provide a general solution to the transgene expression problem. Recently, we described a genetic screen that facilitates the selection of mutant algal strains that express introduced reporter genes to high levels (Neupert et al. 2009). Two mutant strains (UVM4 and UVM11) were isolated from a UV mutagenesis experiment (Neupert et al. 2009) and have quickly become widely used as versatile tools for transgene expression and subcellular localization analyses (e.g., Karcher et al. 2009; Zäuner et al. 2012; Bohne et al. 2013; Lauersen et al. 2013, 2015; reviewed, e.g., in Jinkerson and Jonikas 2015).
In addition to promoter choice and the genetic constitution of the recipient strain, the efficiency of transgene expression is influenced by the properties of the coding region. The Chlamydomonas nuclear genome has an unusually high GC content (Merchant et al. 2007) and genes with low GC content or strongly deviating codon usage are known to be expressed only very poorly or not at all (Fuhrmann et al. 1999; Shao and Bock 2008; Barahimipour et al. 2015). Although GC content and codon usage are connected (in that both are influenced by selective pressure on nucleotide composition of the genome), their relative contributions to expression efficiency are experimentally separable. Expressing YFP gene variants that differ in GC content and/or codon usage, we have recently demonstrated that codon usage, rather than GC content, is the most important determinant of transgene expression efficiency in Chlamydomonas reinhardtii (Barahimipour et al. 2015). Together with the availability of strong promoters (Schroda et al. 2000; Fischer and Rochaix 2001) and algal expression strains that permit high-level transgene expression (Neupert et al. 2009; Karcher et al. 2009), this finding raises hopes that we now have the most important tools required to optimize foreign gene expression in Chlamydomonas and elevate it to levels that are comparable to other systems (such as yeasts and seed plants). This would make the alga competitive with other production platforms in biotechnology and open up new possibilities for its commercial use.
Here, we have applied the knowledge gained about nuclear transgene expression and explored the potential of Chlamydomonas for the expression of two biotechnologically relevant genes: the gene for the HIV-1 antigen P24, a likely indispensable component of any future AIDS vaccine, and the kanamycin resistance gene nptII, a widely used selectable marker gene that, however, does not work well for Chlamydomonas (Hall et al. 1993; Bingham et al. 1989). Originally isolated from the Escherichia coli transposon Tn5, it has quickly become widely used as a selectable marker for transformation experiments in both prokaryotes and eukaryotes. It also represents the by far most frequently used marker for nuclear transformation in seed plants and also works as a selectable marker for chloroplast transformation in tobacco (Nicotiana tabacum; Elghabi et al. 2011; Carrer et al. 1993). However, attempts to develop nptII as a marker for nuclear transformation in Chlamydomonas have remained largely fruitless. Although introduction of nptII as a passenger gene along with a different selectable marker (nitrate reductase; Hall et al. 1993) resulted in clones that displayed low-level kanamycin resistance, direct selection for kanamycin resistance was largely unsuccessful and, in one published study, produced only a single exceptional transformation event (Bingham et al. 1989).
Since the beginning of the acquired immune deficiency syndrome (AIDS) epidemic, 78 million people worldwide have been infected with the human immunodeficiency virus (HIV, mainly with variant HIV-1) and 39 million people have died of the disease (http://www.who.int/gho/hiv/en/). Globally, approximately 35 million people were living with the virus in 2013, and a large number of these infections are located in developing countries. A safe, effective and affordable vaccine that reduces transmission of HIV-1 or, alternatively, prevents disease progression is desperately needed. Unfortunately, despite more than 30 years of intense research efforts, there is still no effective AIDS vaccine on the horizon. The complex biology of the infection process and the high mutation rate of the virus (Trkola 2004) make it likely that a multi-component vaccine comprising several antigenic polypeptides of HIV-1 will be required to invoke broad and potent immunity. Provided that suitable candidate antigens for recombinant subunit vaccines can be identified, crop plants or edible algae (such as Chlamydomonas reinhardtii) would provide the ideal production platform to cheaply produce large quantities of an AIDS vaccine that can be administered orally and is stable even without an uninterrupted cooling chain.
The HIV-1 protein P24 (or p24) forms the conical core of HIV-1 viral particles. P24 represents the largest cleavage product of the precursor polyprotein encoded by the gag gene of the retrovirus. P24 is the target of T cell immune responses in both primary infected and chronically infected AIDS patients. Also, capsid proteins, such as P24, are preferred candidates for vaccine components, because of their high conservation due to structural and functional constraints, thus facilitating the targeting of specific epitopes that lie within conserved domains of the viral particle. As P24 is expected to be a crucial component of any future AIDS vaccine (Obregon et al. 2006), enormous efforts have been undertaken to develop expression strategies for the high-yield and cost-effective production of recombinant P24 protein (Meyers et al. 2008). Proof-of-concept studies in tobacco have shown that the protein can be expressed from the nuclear genome of plants (Zhang et al. 2002; Obregon et al. 2006) and, much more efficiently, from the plastid genome (Zhou et al. 2008; McCabe et al. 2008; Shanmugabalaji et al. 2013). Importantly, several immunogenicity studies with tobacco-derived P24 protein demonstrated elicitation of T cell responses in experimental animals (e.g., Meyers et al. 2008; Gonzalez-Rabade et al. 2011).
In this study, we have compared P24 and nptII gene variants that encode the identical amino acid sequence but differ in codon usage, and tested them in our expression strain UVM11 and a wild type-like strain of Chlamydomonas reinhardtii. We demonstrate that fully codon optimized gene versions introduced into our algal expression strains allow high-level expression of the P24 antigen and turn the nptII gene into an efficient selectable marker gene for Chlamydomonas. Our work reported here establishes straightforward rules for successful transgene expression in Chlamydomonas, and opens up new applications in algal biotechnology.
Materials and methods
Algal strains and culture conditions
The Chlamydomonas reinhardtii cell wall-deficient strains Elow47 and UVM11 (Neupert et al. 2009) were used for all transformation experiments. Both strains are derived from the arginine auxotrophic strain cw15–302 (cwd mt+ arg7). Strain Elow47 was generated by co-transformation of cw15–302 with the CRY1–1 emetine resistance gene and the ARG7 gene providing arginine prototrophy. Strain UVM11 was obtained by UV mutagenesis of Elow47 followed by selection for high transgene expression (Neupert et al. 2009). Algal cells were cultivated mixotrophically in liquid Tris-acetate-phosphate (TAP) medium (Harris, 1989) or on agar-solidified TAP medium at 22 °C under continuous illumination (light intensity: 50–100 µE m−2 s−1), unless otherwise stated.
Construction of transformation vectors
Three gene variants of P24 (encoding the conical core subunit of HIV-1 viral particles) that differ in their GC content and codon usage were generated as follows: NdeI and EcoRI recognition sequences containing a start codon and a stop codon, respectively, were introduced upstream and downstream of the coding regions of all P24 gene variants. Variant P24w is identical to the wild-type P24 sequence (nucleotides 508–1200 of HIV-1, isolate BH10, Gene Bank accession number: M15654.1). Variant CrP24 was codon optimized for the nuclear genome of Chlamydomonas (using the codon frequency table of the Kazusa database: http://www.kazusa.or.jp/codon/) and chemically synthesized (GeneCust). Both versions were cloned as NdeI/EcoRI restriction fragments into pJR38 (Neupert et al. 2009) digested with the same enzymes, giving rise to plasmids pRMB18 and pRMB19, respectively. CpP24, an AT-rich lowly codon-adapted variant (codon optimized for the tobacco chloroplast genome) was amplified from plastid transformation vector pZF1 (Zhou et al. 2008) using primers CpP24NdeIf (5′-AAGCCCATATGCCTATTGTACAAAATATTCAAGG-3′) and CpP24EcoRIr (5′-TGCCAGAATTCTTAGAGTACTCTAGCTTTATG-3′; restriction sites underlined, start and stop codons indicated in bold). The PCR amplicon was cloned into the pCR2.1-TOPO® TA vector and, after sequence confirmation, the CpP24 gene was excised as NdeI/EcoRI restriction fragment and ligated into the similarly digested plasmid pJR38, generating transformation vector pRMB20.
Two gene variants of neomycin phosphotransferase II gene nptII, EcnptII and CrnptII, with identical amino acid sequence but different GC content and codon usage were analyzed. The AT-rich EcnptII sequence (originally from E. coli transposon Tn5) was amplified from plastid transformation vector pRB96 (Wurbs et al. 2007) using primers NptIINdeIf (5′-CAAGCCCATATGGAACAAGATGGATTG-3′) and NptIIEcoRIr (5′-AGAATTCTTAGAAGAACTCGTCAAGAAGGCG-3′; restriction sites underlined, start and stop codons indicated in bold) that introduce NdeI and EcoRI restriction sites at the 5′ and 3′ ends of the gene, respectively. The PCR product was cloned into vector pCR2.1-TOPO® TA (Invitrogen). After sequence confirmation, the NdeI/EcoRI restriction fragment was cloned into the similarly digested plasmid pJR38 (Neupert et al. 2009), resulting in transformation vector pRMB28. The gene sequence of the CrnptII variant was codon optimized according to the preferred codon usage in the Chlamydomonas nuclear genome using the codon frequency table of the Kazusa database (http://www.kazusa.or.jp/codon/) and then chemically synthesized (GeneCust, Dudelange, Luxembourg). Unique NdeI and EcoRI restriction sites at the 5′ and 3′ ends of the gene, respectively, were used for cloning into the similarly digested plasmid pJR38, generating transformation vector pRMB27.
Transformation of Chlamydomonas reinhardtii
Nuclear transformation of the Elow47 and UVM11 strains of Chlamydomonas reinhardtii was performed using the glass bead method and following published protocols (Kindle 1990; Neupert et al. 2012). 1 µg of plasmid DNA linearized with ScaI or NaeI was used for transformation of the P24 variants into the algal genome. Transformants were selected on TAP medium containing 10 µg mL−1 paromomycin. Transformation with the nptII gene variants was performed with 250 ng of gel-eluted (NucleoSpin® Gel and PCR Clean-up kit, Macherey–Nagel, Düren, Germany) XhoI/XbaI restriction fragment containing the nptII coding region and the PSAD promoter and terminator sequences. The aphVIII cassette under the control of the HSP70/RBCS2 promoter was eluted after digestion of pJR38 with restriction enzymes KpnI and XhoI. Transformants were selected on TAP medium supplemented with 25–200 µg mL−1 kanamycin.
DNA isolation, Southern blot analysis and PCR
Total genomic DNA from Chlamydomonas was extracted according to published protocols (Schroda et al. 2001). 100 ng DNA were used as template for PCR assays and 10 µg were used for Southern blot analyses.
To identify transformants that have the complete P24 transformation cassette integrated into their nuclear genome (i.e., the selectable marker gene and the entire transgene of interest), PCR assays were conducted using primer pairs that amplify sequences upstream and downstream of the gene of interest. Primers PPsaDrev (5′ CGAGCCCTTCGAACAGCCAGGCCG 3′) and M13for (5′ GTAAAACGACGGCCAGT 3′) amplified the 5′ end of the PsaD promoter upstream of the coding region of the transgene of interest (380 bp amplicon), and primers APHVIII.rev (5′ CCTCAGAAGAACTCGTCCAACAGCC 3′) and APHVIII.fw (5′ GGAGGATCTGGACGAGGAGCGGAAG 3′) amplified the 3′ end of the aphVIII selectable marker gene (360 bp amplicon). Transformed algal strains yielding both PCR products were selected as positive clones.
For Southern blot analysis, samples of 10 µg DNA were digested with the appropriate restriction enzymes, separated in a 1 % agarose gel, and transferred onto a Hybond™ N+ nylon membrane (GE Healthcare) by capillary blotting. An [α-32P]dCTP-labeled probe was produced by random priming (Megaprime™ DNA labeling system, GE Healthcare) using the complete open reading frame of CrP24 as template. Hybridization took place at 65 °C according to standard protocols.
RNA extraction and northern blot analysis
Total RNA was isolated from algal cultures using the Direct-ZolTM RNA MiniPrep kit (Zymo Research) and following the manufacturer’s protocol. Samples of 10 µg RNA were separated in 1.2 % agarose gels containing 2 % formaldehyde and then transferred onto Hybond™ N+ nylon membranes (GE Healthcare) by capillary blotting. Hybridization was performed at 65 °C using [α-32P]dCTP-labeled probes (GE Healthcare) that were produced by random priming (Megaprime™ DNA labeling system, GE Healthcare). Restriction fragments covering the entire reading frame of the transgene were excised with NdeI and EcoRI from the corresponding transformation vectors and used as templates for probe generation. A 1:1 mixture of CrnptII and EcnptII fragments was used to produce a probe capable of detecting both transcripts with equal sensitivity.
Protein extraction and immunoblot analyses
Total protein was extracted using a phenol-based extraction method (Cahoon et al. 1992). Extraction was performed by resuspension of the cell pellet in extraction buffer [0.7 M sucrose, 0.5 M Tris/HCl, 50 mM EDTA, 0.1 M KCl pH 9.4, 2 % 2-mercaptoethanol and 1× protease inhibitor cocktail cOmplete, EDTA-free (Roche, Darmstadt, Germany)]. An equal volume of phenol (Roti®-Phenol, Roth, Germany) was added, the sample was mixed thoroughly and centrifuged at 15,000×g for 10 min at 4 °C. The supernatant was transferred to a new tube and mixed with five volumes of 0.1 M NH4OAc in methanol. Proteins were precipitated overnight at −20 °C, and pelleted by centrifugation at 15,000×g and 4 °C for 5 min. Pellets were washed with 0.1 M NH4OAc in methanol, air-dried and resuspended in 1 % SDS at 60 °C for 3 min. Protein concentration of the extracts was determined with the BCA assay kit (Pierce, Rockford, IL,USA). Samples of 40 µg protein were separated by electrophoresis in 15 % SDS-PAA gels and subsequently transferred onto PVDF membranes (GE Healthcare, UK) using a standard transfer buffer (192 mM glycine, 25 mM Tris/HCl, pH 8.3). Blocking was performed with either 5 % BSA for detection of P24, or 2.5 % BSA and 2.5 % milk powder for detection of the NptII protein at room temperature for 1 h. Immunodetection of NptII was done with a 1:1000 dilution of rabbit anti-NptII primary antibody (Sigma) and a 1:50,000 dilution of anti-rabbit HRP-conjugated secondary antibody (Agrisera). The P24 protein was detected with a 1:1000 dilution of a monoclonal mouse anti-P24 primary antibody (Abcam) and a 1:5000 dilution of anti-mouse HRP-conjugated antibody (Agrisera). Hybridization signals were visualized by the ECLTM Prime detection system (GE Healthcare).
Antibiotic resistance tests
To compare the phenotypic resistance of aphVIII and CrnptII transformants to different antibiotics, nine independently transformed clones per transgene (initially selected on TAP medium containing 25 µg mL−1 kanamycin) were randomly chosen and maintained on agar-solidified TAP medium without antibiotics. Cultures grown in antibiotic-free liquid TAP medium were used for drop tests on agar-solidified TAP medium containing either 2.5–25 µg mL−1 G418 (G418 disulphate salt solution, Sigma-Aldrich), 5–50 µg mL−1 paromomycin (paromomycin sulphate, Duchefa Biochemie B.V.) or 25-200 µg mL−1 kanamycin (kanamycin monosulphate monohydrate, Duchefa Biochemie B.V.) under constant light of 50 µE m−2 s−1. To determine the level of resistance of EcnptII and CrnptII transformants to different concentrations of kanamycin (0–200 µg mL−1), additional drop tests were performed with dilution series of cultures of the 10 independent transformed strains (initially selected on 50 µg mL−1 kanamycin) that had been characterized by northern blot and immunoblot analyses.
Design of P24 gene variants for expression in Chlamydomonas
Properties of the different P24 and nptII gene variants used in this study
GC content (%)
Overall relative codon adaptation (%)
mRNA and protein accumulation from the different gene variants in wild type-like stains and expression strains
From each of the six transformation experiments, 24 clones were randomly picked and integration of the P24 expression cassette was verified by PCR assays (Fig. 1c; see “Materials and methods” section). On average, 58 % of the UVM11 transformants and 51 % of the Elow47 transformants were found to contain the complete P24 cassette.
Introduction of variants of the kanamycin resistance gene nptII into Chlamydomonas cells
Having confirmed the importance of strain background and codon usage as the two key factors that determine transgene expression efficiency in the nucleus of Chlamydomonas, we reasoned that these principles should also be applicable to the development of new selectable marker genes for algal transformation. A number of selectable marker genes that work in nearly all organisms are very inefficient or do not work at all in Chlamydomonas. The kanamycin resistance gene nptII provides a case in point. Although being a nearly universally applicable marker for transformation in seed plants, attempts to develop nptII as a marker for nuclear transformation in Chlamydomonas have remained largely unsuccessful (Hall et al. 1993; Bingham et al. 1989).
Using glass bead-assisted transformation, the two nptII variants were introduced into Chlamydomonas expression strain UVM11 and the wild type-like strain Elow47 (Neupert et al. 2009). Transformed clones were selected on medium containing a relatively low concentration of kanamycin (50 µg mL−1) to facilitate the selection of transformants also with the non-codon-optimized gene version in strain Elow47. In this way, four sets of transgenic algal clones were generated and subsequently compared with respect to their efficiency of expressing the nptII gene at the mRNA and protein levels.
mRNA and protein accumulation from the two nptII gene variants in strains Elow47 and UVM11
Analysis of nptII mRNA accumulation revealed that the nptII transcript was detectable in nearly all selected clones (Fig. 6a–d), consistent with their kanamycin-resistant phenotype. However, there were significant differences between the four sets of transgenic algal clones in the average expression level of nptII. On average, mRNA accumulation was highest in UVM11 transformed with CrnptII, followed by UVM11 transformed with EcnptII, whereas transcript levels were low in Elow47 transformed with CrnptII, and lowest in Elow47 transformed with EcnptII (Fig. 6a–d). Expression of the nptII gene in all randomly selected UVM11 transformants confirms that the kanamycin selection does not produce a significant fraction of false positive clones (i.e., escapes or spontaneous resistance mutants), a conclusion that is in line with the absence of kanamycin-resistant colonies from control plates with untransformed wild-type cells.
When protein accumulation levels were determined by immunoblot analyses using an anti-NptII antibody, strong NptII accumulation was seen in UVM11 clones transformed with CrnptII (Fig. 6e). Significantly lower levels of NptII accumulated in Elow47 transformed with CrnptII and UVM11 transformed with EcnptII, whereas protein levels were below the detection limit in most Elow47 clones transformed with EcnptII (Fig. 6f–h). As observed with expression of the codon-optimized P24 gene in UVM11, the NptII protein accumulation levels were nearly uniformly high in all tested UVM11-CrnptII clones (Fig. 6e).
In all analyzed UVM11 transformants, the kanamycin resistance phenotype remained stable over time and cultivation cycles in that the clones displayed unaltered drug resistance after half a year of growth under non-selective conditions.
Transformation efficiencies with the two nptII gene variants in strains Elow47 and UVM11
When additionally the two nptII gene variants were compared, selection for medium-level kanamycin resistance (50 µg mL−1) revealed even larger differences. The EcnptII gene variant produced only very low numbers of transformed clones and its transformation frequency in strain Elow47 was approximately 50-fold lower than that of CrnptII in strain UVM11 (Fig. 7b).
Antibiotic resistances conferred by nptII in Chlamydomonas
In this study, we have investigated two transgenes as case studies for the expression of biotechnologically relevant genes from the nuclear genome of the model green alga Chlamydomonas reinhardtii. We selected a protein antigen, the HIV capsid protein P24, and an antibiotic resistance gene (nptII) that works as an efficient selectable marker in many prokaryotic and eukaryotic systems, but does not work well in Chlamydomonas (Hall et al. 1993; Bingham et al. 1989). As previous work had suggested that (i) codon usage is a major determinant of expression efficiency at the level of the gene sequence (Barahimipour et al. 2015), and (ii) greatly improved expression of fluorescent reporter proteins can be achieved in the UVM4 and UVM11 strains (Neupert et al. 2009; Karcher et al. 2009; Barahimipour et al. 2015), we comparatively analyzed codon-optimized and non-optimized gene variants (encoding the identical amino acid sequence), and tested them in both a UVM expression strain and a wild type-like control strain. Our data demonstrate that, for both transgenes, maximum expression levels are obtained when combining the fully codon-optimized coding region with the UVM11 algal expression strain.
Compared to the non-optimized P24 gene versions CpP24 and P24w, the non-codon-optimized nptII gene (EcnptII) performed reasonably well in that, especially in the UVM11 background, it gave rise to detectable gene expression at both the mRNA and the protein levels and also conferred substantial kanamycin resistance (Figs. 6, 7, 8). This is most likely due to the codon usage of the E. coli nptII gene (EcnptII) being closer to the codon usage in the Chlamydomonas nuclear genome than codon usage and GC content of the two non-optimized P24 gene versions (Figs. 1a, b, 5a, b). The unsuccessful expression of the CpP24 and P24w variants indicates that attempts to express AT-rich transgenes with low relative codon adaptation (RCA) are unlikely to be successful in Chlamydomonas.
As noted previously for the YFP reporter gene (Barahimipour et al. 2015), mRNA accumulation and protein abundance in the transgenic algal strains are well correlated (e.g., Figs. 2, 3). As transcription of all gene variants is controlled by exactly the same expression cassette and, therefore, transcription rates are expected to be similar, this correlation may suggest that the high translation rates mediated by the fully codon-optimized synthetic gene versions promote mRNA stability. We, therefore, hypothesize, that the difference in mRNA accumulation observed for the different gene variants is due to the different ribosome coverage of the transcripts. This conclusion is in agreement with recent studies in yeast (Saccharomyces cerevisiae) that revealed a strong impact of translation rates on mRNA stability (Presnyak et al. 2015). A possible mechanistic explanation could be that, similar to the situation in bacteria, translating ribosomes protect the mRNA from endoribonucleolytic attack by RNA-degrading enzymes (Braun et al. 1998; Sunohara et al. 2004; Deana and Belasco 2005).
In contrast to codon usage and strain background, transgene copy number has no pronounced influence on the attainable expression level (Fig. 4). Thus, the two simple recommendations for optimized transgene expression that can be deduced from this study and previous work (Barahimipour et al. 2015) are to (i) use synthetic genes with fully optimized codon usage for the Chlamydomonas nuclear genome, and (ii) introduce the transgenes into a UVM expression strain (Neupert et al. 2009). It is also important to note that, with this strategy, the success rate with transgene expression is close to 100 % in that all transformed UVM11 clones that contained the complete CrP24 cassette also expressed it to high levels, with only moderate variation in expression strength between independent transformants (Fig. 3). A similar observation was made previously when fluorescent reporter genes were expressed in UVM strains (Neupert et al. 2009; Barahimipour et al. 2015).
Genetic engineering technologies are critically dependent on efficient selection systems for transgenic cells. Although by now, a number of useable selectable marker genes have been established for Chlamydomonas (reviewed, e.g., in Weeks 1992; Neupert et al. 2012; Jinkerson and Jonikas 2015; Mussgnug 2015), some of the most efficient markers in other organisms do not work well in Chlamydomonas. In this work, we have tested the idea that this is not due to biochemical or physiological peculiarities of Chlamydomonas cells (e.g., drug uptake or extrusion problems, rapid drug metabolization or sequestration), but rather to the inefficiency with which foreign genes are expressed in the nucleus of the alga. Taking one of the most widely deployed selectable marker genes, the kanamycin resistance gene nptII, as an example, we have shown that this is indeed the case. The codon-optimized CrnptII gene variant expressed in expression strain UVM11 allowed efficient selection of transgenic algal clones on kanamycin concentrations that were similarly high (50-75 µg/mL) or even substantially higher than those conventionally used for the selection of transgenic plants (Figs. 7 and 8). Our results explains why, previously, nptII could not be established as a selectable marker gene for Chlamydomonas transformation (Hall et al., 1993; Bingham et al., 1989). The reason why we obtained a few transformants also with EcnptII in the wild type-like strain Elow47 (1, 2 and 7 clones, respectively, in the three independent transformation experiments) may be that we used a stronger promoter to drive the nptII gene. The PSAD promoter used here controls the expression of an abundant thylakoid protein in the chloroplast (the D subunit of photosystem I) and was shown to be an excellent promoter for transgene expression in Chlamydomonas (Fischer and Rochaix 2001).
In our hands, the optimized nptII used as selectable marker for transformation of the expression strain is similarly efficient as other antibiotic resistance markers commonly employed for transformation of Chlamydomonas, such as hygromycin or paromomycin resistance genes (Berthold et al. 2002; Sizova et al. 2001). Thus, our work provides a new efficient selectable marker gene for Chlamydomonas transformation and also suggests a simple strategy for developing additional markers for selection of transgenic algal cells.
As a result of our efforts to optimize expression of the HIV antigen P24 in Chlamydomonas, recombinant protein accumulation levels of up to 0.25 % of the total cellular protein were reached (Fig. 3). Previous attempts to express P24 from the tobacco nuclear genome led to accumulation levels of up to 0.35 % of the plant’s total soluble protein (Zhang et al. 2002). Considering that a value expressed as total soluble protein is probably approximately one-third higher than the corresponding value expressed as total cellular protein, the expression levels achieved in tobacco and Chlamydomonas are remarkably similar. This suggests that the combination of codon-optimized synthetic genes with our expressions strains largely overcomes the transgene expression problem in Chlamydomonas and makes the alga competitive with seed plants as an expression host for recombinant proteins. Although several other algae (e.g., some Chlorella species) can be grown to higher cell densities than Chlamydomonas, which is a potential advantage for applications requiring high biomass production, the molecular toolboxes currently available for other algal species do not even come close to that available for Chlamydomonas. Also, for many applications, such as the production of high-value biopharmaceuticals, the costs of biomass production are negligible compared the costs for downstream processing and purification which, to a large extent, are determined by the attainable protein accumulation level in the cell (Ma et al., 2005). Finally, we expect that the tools and guidelines for optimized transgene expression, as developed for Chlamydomonas, will also be applicable to other algal species.
In summary, the application of the optimization strategies described here will considerably expand the range of biotechnological applications that can be pursued in Chlamydomonas and other algae, and likely will facilitate new approaches in metabolic pathway engineering and molecular farming (Scaife et al. 2015).
We thank Dr. Marc Lohse for help with codon optimization. This work was supported by the Max Planck Society and a Ph.D. fellowship from the Ministry of Science, Research and Technology of Iran to R. Barahimipour and grants from the Deutsche Forschungsgemeinschaft and the Bundesministerium für Bildung und Forschung to R. Bock.
R.Ba, J.N and R.Ba designed the research, R.Ba performed experiments, R.Ba, J.N and R.Bo analyzed data, R.Bo wrote the manuscript with feedback from R.Ba and J.N.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.